Back to Search
Start Over
China's Kangtai commences mid-stage trial of its experimental COVID-19 vaccine candidate
- Source :
- M2 Pharma. October 29, 2020
- Publication Year :
- 2020
-
Abstract
- M2 PHARMA-October 29, 2020-China's Kangtai commences mid-stage trial of its experimental COVID-19 vaccine candidate (C)2020 M2 COMMUNICATIONS Chinese Clinical Trial Registry has revealed that Shenzhen Kangtai Biological Products (Kangtai), a [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.639778625